New treatment for rickets approved by FDA

18 Apr 2018


The FDA has approved the drug burosumab to treat X-linked hypophosphatemia, a rare form of rickets. 

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story